06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1158 22 1148 81 986 166 1011
ERLYTX 77 1 52 3 37 7 43
GI 165 4 209 13 158 26 158
GU 391 9 470 40 487 91 554
LEUK 161 1 52 15 183 28 170
LUNG 205 4 209 13 158 26 158
LYMPH 424 8 417 31 377 65 396
MELAN 8 1 52 1 12 1 6
MMYEL 116 4 209 16 195 20 122
MULT 51 0 0 1 12 2 12
OTHER 44 1 52 1 12 3 18
Total 2800 55 2870 215 2617 435 2648

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 209 2 104 18 219 36 219
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 0 0 2 24 3 18
LEUK 613 11 574 51 621 102 621
LUNG 374 12 626 37 450 59 359
OTHER 15 0 0 2 24 6 37
PEOLC 69 3 157 3 37 4 24
PREV 231 9 470 20 244 28 170
SXQOL 659 9 470 49 597 98 597
Total 2178 46 2401 182 2216 337 2051

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1158 22 1148 81 986 166 1011
CCD 209 2 104 18 219 36 219
ERLYTX 79 1 52 3 37 7 43
GI 166 4 209 13 158 27 164
GU 396 9 470 42 511 94 572
LEUK 774 12 626 66 804 130 791
LUNG 579 16 835 50 609 85 517
LYMPH 424 8 417 31 377 65 396
MELAN 8 1 52 1 12 1 6
MMYEL 116 4 209 16 195 20 122
MULT 51 0 0 1 12 2 12
OTHER 59 1 52 3 37 9 55
PEOLC 69 3 157 3 37 4 24
PREV 231 9 470 20 244 28 170
SXQOL 659 9 470 49 597 98 597
Total 4978 101 5271 397 4835 772 4699

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 705 13 678 46 560 89 542
ERLYTX 55 1 52 3 37 5 30
GI 124 1 52 8 97 20 122
GU 288 6 313 26 317 60 365
LEUK 100 0 0 7 85 15 91
LUNG 129 2 104 8 97 18 110
LYMPH 276 4 209 19 231 41 250
MELAN 8 1 52 1 12 1 6
MMYEL 65 3 157 9 110 11 67
MULT 20 0 0 1 12 1 6
OTHER 44 1 52 1 12 3 18
Total 1814 32 1669 129 1570 264 1607

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 155 0 0 14 170 26 158
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 0 0 2 24 3 18
LEUK 248 4 209 19 231 33 201
LUNG 225 6 313 24 292 37 225
OTHER 15 0 0 2 24 6 37
PEOLC 56 3 157 3 37 4 24
PREV 229 7 365 18 219 26 158
SXQOL 481 6 313 34 414 74 450
Total 1417 26 1357 116 1411 210 1277

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 898 19 991 69 840 131 797
CCD 171 0 0 10 122 23 140
ERLYTX 57 1 52 3 37 5 30
GI 139 2 104 11 134 27 164
GU 327 6 313 29 353 70 426
LEUK 351 4 209 26 317 49 298
LUNG 383 8 417 31 377 62 377
LYMPH 276 4 209 19 231 41 250
MELAN 8 1 52 1 12 1 6
MMYEL 65 3 157 9 110 11 67
MULT 43 3 157 5 61 10 61
OTHER 128 1 52 3 37 9 55
PEOLC 57 0 0 3 37 3 18
PREV 229 7 365 18 219 26 158
SXQOL 481 6 313 34 414 74 450
Total 3613 65 3391 271 3301 542 3297

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 991 20 1044 77 937 154 937
ERLYTX 72 1 52 3 37 7 43
GI 100 3 157 10 122 18 110
GU 280 9 470 30 365 65 396
LEUK 131 1 52 14 170 24 146
LUNG 181 4 209 12 146 24 146
LYMPH 349 8 417 28 341 53 323
MMYEL 103 3 157 15 183 19 116
MULT 51 0 0 1 12 2 12
Total 2258 49 2558 190 2313 366 2229

06-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1888 39 2035 143 1741 281 1711
AFFIL 127 1 52 2 24 6 37
CCOP/NCORP 1216 18 939 100 1218 187 1138
Non-SWOG 1744 40 2087 149 1814 295 1796
Total 4975 98 5113 394 4797 769 4682

06-OCT-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

06-OCT-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26
OTHER NRGHN009 HN, RT + HD Cisp vs RT + LD Cisp for SCCHN 1 E 02-OCT-26

06-OCT-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 18
LUNG LUNGMAP NSCLC, Adv, Master 1 12
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 8
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 8
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 7
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 3 4
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 4
PEOLC S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 2 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 3
MULT S2101 Melan or HNSCC, Adv, Cabo + Nivo 1 3
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 3